Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Goals
Fat LossMuscle BuildingInjury HealingAnti-AgingCognitive EnhancementSleep OptimizationImmune SupportGut HealingSkin RejuvenationSexual Health
Peptides
5-Amino-1MQ
Weight Management
Abarelix
Hormone Support
Acetyl Hexapeptide-3 (Argireline)
Cosmetic
Adipotide
Weight Management
Adrenomedullin
Healing & Recovery
Alexamorelin
Growth Hormone
Angiotensin (1-7)
Healing & Recovery
AOD-9604
Weight Management
Apelin-13
Healing & Recovery
ARA-290 (Cibinetide)
Healing & Recovery
Bestatin (Ubenimex)
Immune
BPC-157
Healing & Recovery
Buserelin
Hormone Support
Cagrilintide
Weight Management
CagriSema
Weight Management
Capromorelin
Growth Hormone
Cartalax
Anti-Aging
Cathelicidin (hCAP-18 / Synthetic Derivatives)
Immune
Cerebrolysin
Cognitive
Cerluten
Cognitive
Cetrorelix
Hormone Support
Chonluten
Immune
CJC-1295 (No DAC)
Growth Hormone
CJC-1295 with DAC
Growth Hormone
Cortexin
Cognitive
Crystagen
Immune
Daptomycin
Immune
Defensin (HBD-2)
Immune
Defensin (HBD-3)
Immune
Degarelix
Hormone Support
Dihexa
Cognitive
DSIP (Delta Sleep-Inducing Peptide)
Sleep & Recovery
Dulaglutide
Weight Management
Enalapril
Healing & Recovery
Epithalon
Anti-Aging
Exenatide
Weight Management
Fertirelin
Hormone Support
FOXO4-DRI
Anti-Aging
Ganirelix
Hormone Support
GHK-Cu (Copper Peptide)
Cosmetic
GHRH (1-29)
Growth Hormone
GHRP-2
Growth Hormone
GHRP-6 (Growth Hormone Releasing Peptide-6)
Growth Hormone
Glutathione
Anti-Aging
Gonadorelin (GnRH)
Hormone Support
Gramicidin
Immune
Hexarelin
Growth Hormone
Human Chorionic Gonadotropin (HCG)
Hormone Support
Human Growth Hormone (HGH)
Growth Hormone
IGF-1 LR3
Growth Hormone
Immunoxel (Dzherelo)
Immune
Imunofan
Immune
Intermedin (Adrenomedullin-2)
Healing & Recovery
Ipamorelin
Growth Hormone
Kisspeptin-10
Sexual Health
KPV (Alpha-MSH Fragment)
Healing & Recovery
Lactoferricin B
Immune
Larazotide
Healing & Recovery
Lentinan
Immune
Leuphasyl
Cosmetic
Leuprolide
Hormone Support
Liraglutide
Weight Management
Livagen
Anti-Aging
Lixisenatide
Weight Management
LL-37
Immune
Macimorelin
Growth Hormone
Magainin-2
Immune
Mazdutide
Weight Management
Melanotan-2
Cosmetic
MK-677 (Ibutamoren)
Growth Hormone
MOTS-c
Metabolic
Myristoyl Pentapeptide-17
Cosmetic
N-Acetyl Selank
Cognitive
N-Acetyl Semax Amidate
Cognitive
NAD+
Mitochondrial
Nafarelin
Hormone Support
Natriuretic Peptide (ANP)
Healing & Recovery
Nesiritide (BNP)
Healing & Recovery
Nisin
Immune
Noopept (Omberacetam)
Cognitive
Orforglipron
Weight Management
Ovagen
Anti-Aging
Oxytocin Acetate
Hormone Support
P21 (P021)
Cognitive
PACAP-38
Healing & Recovery
Palmitoyl Oligopeptide
Cosmetic
Palmitoyl Pentapeptide-4 (Matrixyl)
Cosmetic
Palmitoyl Tetrapeptide-7
Cosmetic
Palmitoyl Tripeptide-1
Cosmetic
Pancragen
Metabolic
PEG-MGF
Healing & Recovery
Pemvidutide
Weight Management
Pentadecapeptide (BPC Analog)
Healing & Recovery
Pidotimod
Immune
Pinealon
Cognitive
PNC-27
Immune
Polymyxin B
Immune
Pralmorelin (GHRP-2)
Growth Hormone
Pramlintide
Weight Management
Prostamax
Hormone Support
PT-141 (Bremelanotide)
Sexual Health
Relaxin-2 (Serelaxin)
Healing & Recovery
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Setmelanotide
Weight Management
SLU-PP-332
Metabolic
SM-130686
Growth Hormone
Snap-8
Cosmetic
SS-31 (Elamipretide)
Mitochondrial
Substance P Antagonists
Healing & Recovery
Survodutide
Weight Management
SYN-AKE
Cosmetic
Tabimorelin
Growth Hormone
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Testagen
Hormone Support
Thymalin
Immune
Thymopentin (TP-5)
Immune
Thymopoietin
Immune
Thymosin Alpha-1
Immune
Thymosin Beta-4
Healing & Recovery
Thymulin (FTS)
Immune
Thymulin Analog (PAT)
Healing & Recovery
Tirzepatide
Weight Management
Tripeptide-29
Cosmetic
Triptorelin
Hormone Support
Ularitide
Healing & Recovery
Urocortin
Healing & Recovery
Ventfort
Anti-Aging
Vesilute
Hormone Support
Vilon
Immune
VIP (Vasoactive Intestinal Peptide)
Healing & Recovery
Xenin-25
Metabolic
Ziconotide (Prialt)
Healing & Recovery
Total Peptides: 137
Back to Home
Back to Cetrorelix

Clinical trials

Every registered trial of Cetrorelix

125 studies, 11 still enrolling.

Plain-Language Summary

Plain-language reading of the public trial registries.

In short

  • Cetrorelix has a real but limited body of human research.
  • 125 registered studies in total.
  • 11 are still enrolling people, so this is active research, not just history.

What kind of research

  • 117 studies actually gave the peptide to volunteers and measured what happened. This is the kind of study that can show whether something works.
  • About 21,563 people took part in those.
  • A further 8 studies only looked at records of people already taking it. These are counted separately because nobody was given the peptide for the study, so they cannot prove cause and effect.

How far along it is

  • 59 trials have reached phase 3 or 4 — the large, late-stage trials regulators rely on to approve a drug.
  • 24 have published results in the medical literature that anyone can read.
  • The research spans 40 countries.

A registered trial is a plan, not a result. Registration means a study was declared in advance; it says nothing about whether the peptide worked, and a trial can be registered and then abandoned.

Filter

Showing 125 of 125 trials for Cetrorelix.

  • NCT07732348Not Yet Recruiting195 enrolled2026

    Oral GnRH Antagonist (Linzagolix) Versus Injectable GnRH Antagonist and Progestin-primed Ovarian Stimulation (PPOS) in Controlled Ovarian Stimulation for in Vitro Fertilization: a Prospective Comparative Observational Study

    Centro A.M.B.R.A. (Associazione Medici e Biologi per la Riproduzione Assistita)

    Infertility, Female · Ovulation Induction

  • NCT07736261Phase 1/2Not Yet Recruiting100 enrolled2026

    Drospirenone-Primed Ovarian Stimulation Versus GnRH Antagonist Protocol in Poor Ovarian Responders Undergoing Freeze-All IVF/ICSI

    Ahmed Saad

    Poor Ovarian Reserve · Infertility (IVF Patients)

  • NCT05326087Phase 3Not Yet Recruiting204 enrolled2026

    Comparison of the Euploid Rate of Blastocyst Between PPOS and GnRH Antagonist Protocol in Women With PCOS Undergoing PGT-A

    ShangHai Ji Ai Genetics & IVF Institute

    Preimplantation Genetic Testing · Progestin-primed Ovarian Stimulation · Polycystic Ovarian Syndrome · GnRH Antagonist

  • NCT07340827Phase 3Recruiting266 enrolled2026

    A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH and FSH Deficiency Undergoing ART (HINATA)

    Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

    Infertility

  • NCT07350317Phase 4Not Yet Recruiting230 enrolled2026

    Trial Comparing Subcutaneous Natural Progesterone (Prolutex) vs. Cetrorelix Acetate for Luteinizing Hormone Surge Suppression in Freeze-All IVF Cycles.

    Trust Fertility Clinic

    Assisted Reproductive Techniques

  • 2024-516282-37-00Ongoing100 enrolled2025

    ICO-N-2013-03

    Institut De Cancerologie De L Ouest

    Breast cancer

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT06572930Recruiting150 enrolled2024

    Serum FSH Monitoring for Identification of an Optimal Range During Ovarian Stimulation

    ART Fertility Clinics LLC

    Ovarian Stimulation

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT06608186Phase 1/2Completed50 enrolled2024

    Can Drospirenone be Used to Prevent LH Surge in Controlled Ovarian Stimulation in PCOS?!

    Ahmed Saad

    PCOS (Polycystic Ovary Syndrome)

  • 2024-514035-19-00Ongoing120 enrolled2024

    PErsonalized Addition of Recombinant LH in suboptimal responders >35 years old (POSEIDON group 2). A randomized controlled trial

    Santiago Dexeus Font Fundacio Privada

    infertility

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT06571214Phase 4Not Yet Recruiting300 enrolled2024

    Potential Benefit of r-hLH Addition in Patients Aged 35 to 40 Under Ovarian Stimulation Treatment

    Nanjing University

    Infertility

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT06212102Phase 2Recruiting120 enrolled2024

    Dydrogesterone Versus GnRH Antagonist in Poor Responders Undergoing Double Ovarian Stimulation

    Bedaya Hospital

    Infertility

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT06378268Active Not Recruiting626 enrolled2024

    PPOS vs GnRH Antagonist in Ovarian Stimulation (ProGanOS Study)

    Mỹ Đức Hospital

    Progestins Primed Ovarian Stimulation

  • NCT06023602Recruiting1,338 enrolled2024

    Effectiveness of Generic Versus Reference Cetrorelix Acetate for Ovarian Stimulation Using a Gonadotropin-releasing Hormone(GnRH)Antagonist Protocol in Women Undergoing IVF

    Northwest Women's and Children's Hospital, Xi'an, Shaanxi

    Infertility

  • NCT05951400Phase 2/3Completed200 enrolled2024

    Progesterone Primed Protocol Versus GnRH Antagonist in With PCO Undergoing ICSI

    Beni-Suef University

    IVF · PCO

  • NCT06812559Completed100 enrolled2023

    Progesterone Primed Ovarian Stimulation Versus GnRH Antagonist Protocols in Women With Polycystic Ovarian Syndrome

    El Shatby University Hospital for Obstetrics and Gynecology

    Controlled Ovarian Hyperstimulation · Polycystic Ovarian Syndrome

  • NCT05738382Phase 2Unknown240 enrolled2023

    Efficacy and Safety of BG2109 During Controlled Ovarian Hyperstimulation in Female Subjects Undergoing ART Procedures

    Bio Genuine (Shanghai) Biotech Co., Ltd.

    Assisted Reproductive Technology · Controlled Ovarian Hyperstimulation

  • NCT05972902Phase 3Unknown387 enrolled2023

    Dydrogesterone, Cetrorelix Acetate and Triptorelin in Intra Cytoplasmic Sperm Injection Outcomes

    Beni-Suef University

    IVF

  • NCT04931355Unknown90 enrolled2023

    Acupuncture in the Freeze-all IVF Cycle

    Peking University Third Hospital

    Acupuncture · Female Infertility

  • NCT05847660Unknown210 enrolled2023

    Progesterone Primed Ovarian Stimulation Protocol Versus Antagonist Protocol for PCO Patient

    Fayoum University

    Polycystic Ovary Syndrome · Infertility · IVF

  • NCT05767086Completed297 enrolled2023

    Comparison of 3 Different Protocols for Preventing Premature Ovulation in Ovarian Stimulation Cycles

    Bezmialem Vakif University

    Infertility

  • NCT05751681Unknown79 enrolled2023

    Dydrogesterone-Primed Ovarian Stimulation Protocol Versus Gonadotropin Releasing Hormone Antagonist Protocol in ICSI

    Zagazig University

    Ovary Cyst · Fertility Issues

  • NCT06868576Phase 3Completed328 enrolled2023

    PPOS Protocol Versus GnRH Anatagonist for Expected Normal Responder Patients Undergoing ART : a Randomized Clinical Trial

    Kasr El Aini Hospital

    PPOS · GnRH Antagonist · Assisted Reproductive Techniques

  • NCT06297564Completed40 enrolled2022

    Progesterone Primed Endometrial Protocol Versus Gonadotropin-releasing Hormone Antagonist Protocol in Assisted Reproductive Treatments

    New Valley University

    Progesterone Primed Endometrial Protocol · Gonadotropin Releasing Hormone Antagonist Protocol · Assisted Reproductive Treatments

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT05447208Phase 3Recruiting400 enrolled2022

    Effect of GH on the Blastocyst Euploid Rate in AMA Patients

    ShangHai Ji Ai Genetics & IVF Institute

    Preimplantation Genetic Testing · Growth Hormone · Age, Parental

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT06778733Early Phase 1Completed22 enrolled2022

    Effectiveness of Low Dose Gonadotropin Stimulation Protocol Vs High Dose Gonadotropin Protocol in Poor Responders

    University of Athens

    Female Infertility

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT05112692Unknown200 enrolled2021

    Progestin-primed Ovarian Stimulation Protocol Versus GnRH Antagonist Protocol in Polycystic Ovary Syndrome Patients Undergoing IVF/ICSI Cycles

    Mansoura University

    PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries

  • NCT04989348Completed240 enrolled2021

    Euploid Rate of Blastocyst Derived From PPOS VS Antagonist Protocol

    Shanghai First Maternity and Infant Hospital

    IVF

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT04935073Phase 3Unknown90 enrolled2021

    Traditional Chinese Medicine Herbs in the Freeze-all IVF Cycle

    Peking University Third Hospital

    Infertility, Female

  • NCT04819204Unknown20 enrolled2021

    Testosterone and Neurovascular Control in Humans

    Western University, Canada

    Healthy

  • NCT05939284Completed238 enrolled2021

    Progesterone-Primed Ovarian Simulation in Controlled-ovarian Simulation of Infertile PCOS Patients

    Zagazig University

    PCOS

  • NCT04993924Phase 4Unknown15 enrolled2021

    GnRH Antagonist Pre-treatment in the Early Follicular Phase for Resolution of a Baseline Functional Ovarian Cyst

    Assaf-Harofeh Medical Center

    IVF · Ovarian Cysts

  • NCT04842825Phase 3Unknown200 enrolled2021

    Sequential Therapy of TCM Herbs to Improve the Success Rate of IVF-ET in Diminished Ovarian Reserve Patients

    Peking University Third Hospital

    Infertility, Female

  • NCT04754243Phase 4Unknown200 enrolled2021

    New Protocol in Unexplained Infertility

    Tanta University

    Unexplained Infertility

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT04719000Phase 4Recruiting120 enrolled2021

    PErsonalized Addition of Recombinant LH in Ovarian Stimulation

    Fundación Santiago Dexeus Font

    Infertility

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT04537078Phase 3Completed90 enrolled2020

    Progestin Primed Double Stimulation Protocol Versus Flexible GnRH Antagonist Protocol in Poor Responders

    El Shatby University Hospital for Obstetrics and Gynecology

    Infertility, Female

  • NCT04727684Phase 4Completed50 enrolled2020

    Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology in Polycystic Ovary Syndrome Patients During IVF/ICSI

    Damascus University

    In Vitro Fertilization · Infertility · Intracytoplasmic Sperm Injection · Polycystic Ovary Syndrome

  • NCT04724486Phase 4Completed50 enrolled2020

    Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology During IVF/ICSI

    Damascus University

    In Vitro Fertilization · Intracytoplasmic Sperm Injection · Infertility

  • NCT04414748Phase 3Completed400 enrolled2020

    Comparison of the Euploid Rate of Blastocyst Between PPOS and GnRH Antagonist Protocol in Patients Undergoing PGT-A

    ShangHai Ji Ai Genetics & IVF Institute

    Preimplantation Genetic Testing · Progestin-primed Ovarian Stimulation · Euploid Rate · GnRH Antagonist

  • NCT04414761Phase 3Completed784 enrolled2020

    Live Birth Rate Between PPOS and GnRH Antagonist Protocol in Patients With Anticipated High Ovarian Response

    ShangHai Ji Ai Genetics & IVF Institute

    IVF · GnRH Antagonist · PPOS

  • NCT03680053Terminated220 enrolled2020

    Comparison of the Live Birth Rate Between the PPOS and the GnRH Antagonist Protocol in Patients Undergoing IVF

    ShangHai Ji Ai Genetics & IVF Institute

    Infertility · ART

  • NCT04308343Unknown120 enrolled2020

    The Aromatase Inhibitor and Gnrh Antagonist Versus Methotrexate for Management of Undisturbed Ectopic Pregnancy

    Assiut University

    Ectopic Pregnancy

  • NCT04724343Phase 4Completed50 enrolled2019

    Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes.

    Damascus University

    In Vitro Fertilization · Intracytoplasmic Sperm Injection · Infertility

  • NCT04727671Phase 4Completed50 enrolled2019

    Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes in Polycystic Ovary Syndrome Patients.

    Damascus University

    In Vitro Fertilization · Intracytoplasmic Sperm Injection · Infertility · Polycystic Ovary Syndrome

  • NCT04094467Phase 4Unknown150 enrolled2019

    Comparison Between Two Different Protocols in Polycystic Ovary Symdrome Women Undergoing Intra-cytoplasmic Injection

    Assiut University

    Polycystic Ovary Syndrome

  • NCT04108039Completed44 enrolled2019

    Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles.

    Fundacion Dexeus

    Infertility · IVF · Preimplantation Diagnosis

  • NCT04052607Terminated56 enrolled2019

    Progestin Priming Ovarian Stimulation (PPOS) Compared With Antagonist Protocol for Freeze-all Cycles

    Ibn Sina Hospital

    Infertility

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT06199960Phase 3Completed116 enrolled2019

    Dual Ovarian Stimulation (Duostim) and Shanghai Protocols in Poor Ovarian Responders

    Royan Institute

    Assisted Reproductive Techniques

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT03996434Phase 4Completed300 enrolled2019

    Coasting Versus Antagonist Protocol in Patients at High Risk of OHSS

    ClinAmygate

    Ovarian Hyperstimulation Syndrome

  • NCT03809429Phase 3Completed437 enrolled2019

    Follitropin Delta in Long GnRH Agonist and GnRH Antagonist Protocols (BEYOND)

    Ferring Pharmaceuticals

    Infertility, Female

  • NCT04026282Unknown888 enrolled2018

    To Investigate the Cumulative Live Birth Rates Using GnRH Antagonist or Agonist Protocol for COS in ART Treatment

    Peking University Third Hospital

    Sterility

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT03759301Phase 4Completed156 enrolled2018

    Efficacy of Growth Hormone Supplementation With Gonadotrophins in IVF/ICSI for Poor Responders

    ClinAmygate

    Infertility, Female

  • NCT03763786Phase 4Unknown300 enrolled2018

    Frozen Embryo Transfer With GnRH-antagonist Trial

    University of Oxford

    Infertility

  • NCT04671966Phase 4Unknown100 enrolled2018

    Sex Differences in Myocardial Steatosis Induced Left Ventricular Dysfunction

    The University of Texas at Arlington

    Heart Diseases · Left Ventricular Dysfunction

  • NCT04268927Phase 2Unknown106 enrolled2018

    Extended Letrozole Regimen Co-treatment With Gonadotropin Releasing Hormone Antagonist Protocol Versus Gonadotropin Releasing Hormone Antagonist Protocol in Poor Responders Undergoing IVF-ET

    Cairo University

    Infertility

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT04071574Phase 1/2Completed200 enrolled2018

    Comparative Study on the Efficacy of Ovarian Stimulation Protocols on the Success Rate of ICSI in Female Infertility

    Lebanese University

    Female Infertility · Female Infertility Due to Ovulatory Disorder · Premature Ovarian Failure · Polycystic Ovary Syndrome

  • NCT03291821Completed136 enrolled2017

    DuoStim in Cases of PGT: Comparison of Embryo Quantity and Embryonic Quality Using MitoScore

    IVI Madrid

    Infertility, Female

  • NCT03477929Phase 4Unknown100 enrolled2017

    Cetrorelix and Ganirelix Flexible Protocol for (IVF)

    Università degli Studi 'G. d'Annunzio' Chieti e Pescara

    Infertility/Sterility

  • NCT03139474Phase 2/3Unknown120 enrolled2017

    Impact of Gonadotrophin Releasing Hormone Analogues on Oocyte and Embryo Quality

    Assiut University

    Infertility, Female

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT03118830Phase 4Completed204 enrolled2017

    Long Protocol and Freeze All Embryos vs Antagonist Protocol With Fresh Embryo Transfer in PCOS Patients Undergoing ICSI

    Cairo University

    Invitro Fertilization

  • NCT02892942Phase 4Completed129 enrolled2017

    NATural Ovarian Stimulation

    Assistance Publique - Hôpitaux de Paris

    Infertility

  • NCT02821819Phase 4Terminated15 enrolled2017

    Random-start Ovarian Stimulation in Egg-donors (ROSE)

    Instituto Bernabeu

    Infertility

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT03044756Phase 2/3Unknown100 enrolled2017

    Omitting GnRH-antagonist Dose on the Day of Ovulation Trigger

    Assiut University

    Pituitary Downregulation

  • NCT05577806Completed202 enrolled2017

    DYG Versus Cetrorelix in Oocyte Donation

    Clinica de la Mujer Medicina Reproductiva, Chile

    Infertility, Female · Fertility Disorders

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT03181685Phase 4Terminated60 enrolled2016

    Patients' Preference for Subcutaneous or Vaginal Progesterone as Luteal Support in IVF/ICSI Cycles

    Andros Day Surgery Clinic

    Infertility · In Vitro Fertilization

  • NCT03876145Completed120 enrolled2016

    The Four Methods of Ovarian Stimulation in Patients With Polycystic Ovarian Syndrome

    Royan Institute

    Polycystic Ovary Syndrome · Ovarian Hyperstimulation Syndrome

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT02889380Completed3,000 enrolled2016

    A Retrospective Study in Chinese Good Prognosis Patients Undergoing Assisted Reproductive Technology (ART) Treatment

    Merck KGaA, Darmstadt, Germany

    Infertility

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT04008966Phase 4Completed160 enrolled2016

    Comparative Study Between Single Versus Dual Trigger for Poor Responders in GnRH-antagonist ICSI Cycles

    Cairo University

    Assisted Reproduction

  • NCT02478775Completed99 enrolled2015

    Dysregulation of FSH in Obesity: Functional and Statistical Analysis

    University of Colorado, Denver

    Obesity · Fertility

  • NCT02392520Unknown40 enrolled2015

    Luteal Antagonist Versus Conventional Treatment in Women With Severe Early Ovarian Hyperstimulation Syndrome (OHSS)

    Eugonia

    Ovarian Hyperstimulation Syndrome

  • NCT03457233Unknown185 enrolled2015

    The Impact of Body Weight on Reproductive Outcomes in Poor Ovarian Responders in ICSI Cycles

    Cairo University

    Invitro Fertilization

  • NCT02335736Phase 2Unknown200 enrolled2015

    Antagonist Protocol in IVF

    Woman's Health University Hospital, Egypt

    Infertility

  • NCT02333253Phase 3Completed60 enrolled2015

    Delayed Start Versus Conventional Antagonist Protocol in Poor Responders Pretreated by Estradiol in Luteal Phase

    Cairo University

    Other Complications Associated With Artificial Fertilization

  • NCT02823080Phase 2/3Unknown48 enrolled2014

    Outcome of Cetrotide Therapy for Management of Women at High-risk of Ovarian Hyperstimulation Syndrome

    Benha University

    Infertility

  • NCT02195947Phase 4Completed141 enrolled2014

    Antagonist Protocol in Poor Responders

    Cairo University

    Female Infertility Due to Diminished Ovarian Reserve

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT02784457Phase 2Completed84 enrolled2014

    Gonadotropin Releasing Hormone Antagonist in Treatment of Early-onset Severe Ovarian Hyperstimulation Syndrome

    Ain Shams University

    Assisted Reproduction

  • NCT02820415Completed60 enrolled2014

    PGS on Blastocysts From Vitrified and Fresh Oocytes

    Unità di Medicina della Riproduzione, Italy

    Increase the Number of Blastocyst to Biopsy for Preimplantation Genetic Testing

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT02442895Completed236 enrolled2014

    Biomarkers of Ovarian Reserve and Correlation With IVF Treatments

    U.O.S. Procreazione Medicalmente Assistita e Congelamento Gameti

    Pregnancy, Ovarian

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT02890082Phase 2Active Not Recruiting102 enrolled2014

    Preservation of Fertility by Ovarian Stimulation Associated With Tamoxifen, Prior Chemotherapy for Breast Cancer

    Institut Cancerologie de l'Ouest

    Breast Cancer

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT02201914Phase 4Unknown250 enrolled2014

    Clomiphene Citrate Plus Gonadotropins and GnRH Antagonist Versus Flexible GnRH Antagonist Protocol Versus Microdose GnRH Agonist Protocol in Poor Responders Undergoing IVF

    Bioroma

    Poor Responders · IVF · Clomiphene Citrate · GnRH Agonist

  • NCT01948804Phase 4Unknown100 enrolled2014

    The Comparison of Effect of Four Different Treatment Protocols on IVF Outcomes in Poor Responders Undergoing in Vitro Fertilization.

    Pınar Özcan Cenksoy

    Poor Responders Undergoing IVF

  • NCT02042196Early Phase 1Completed100 enrolled2013

    Sex Hormones and Atherosclerosis Prevention in Perimenopausal Women

    University of Colorado, Denver

    Menopause · Aging

  • NCT01926210Phase 4Unknown500 enrolled2013

    Comparison of Ovarian Mild Stimulation and Controlled Ovarian Stimulation in Poor Ovarian Responders

    Huang Rui

    Infertility

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT02640976Early Phase 1Completed216 enrolled2013

    Poor Ovarian Stimulation Response in In Vitro Fertilization (IVF) Program

    Cairo University

    Infertility

  • NCT03484611Unknown179 enrolled2013

    Prediction of Metaphase II Oocytes According to Different Levels of Serum AMH in Poor Responders Using the Antagonist Protocol

    Cairo University

    Invitro Fertilizaion

  • NCT01760278Phase 4Unknown200 enrolled2012

    Assessment of Implantation Potential of Embryos by Time-lapse Technology

    Bloom IVF and Fertility Centre

    Embryo/Fetus Death · Blastocyst Disintegration · Aneuploidy · Complication of Implant

  • NCT01709942Phase 3Completed80 enrolled2012

    Use of Degarelix in Controlled Ovarian Hyperstimulation (COH) Protocol for Women With PoliCystic Ovarian Syndrome (PCOS)

    Centre for Endocrinology and Reproductive Medicine, Italy

    PCOS · OHSS · INFERTILITY

  • NCT01669291Completed43 enrolled2012

    Effect of GnRH Antagonist vs Agonist Long on IVF Outcome, Peak Estradiol Level,and Duration of Stimulation

    Main Line Fertility Center

    Fertility

  • NCT01616225Phase 2/3Terminated60 enrolled2012

    Growth Hormone in Poor Responders to IVF Trial

    Pacific Centre for Reproductive Medicine

    Infertility

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT01565265Completed5 enrolled2012

    Comparing Ovarian Stimulation for Assisted Reproduction With Two Different Forms of Pituitary Suppression

    University Hospital, Basel, Switzerland

    Female Infertility Due to Nonimplantation of Ovum · Complications Associated With Artificial Fertilization

  • NCT01268761Phase 3Completed100 enrolled2012

    GnRH Antagonist for Treatment of Early Ovarian Hyperstimulation Syndrome

    Instituto Valenciano de Infertilidad, IVI VALENCIA

    Ovarian Hyperstimulation Syndrome · Effects of Gonadotropin · Oocyte Maturation

  • NCT01595334Unknown300 enrolled2012

    Study on Influence of Leutinizing Hormone (LH) on Oocyte Maturity

    Southern Cross Fertility Centre

    Infertility

  • NCT01468441Completed96 enrolled2011

    Ovarian Stimulation Using Recombinant Follicle-stimulating Hormone (FSH) and Gonadotrophin Releasing Hormone (GnRH) Agonist in Alternate Days

    Fertility - Assisted Fertilization Center

    Infertility

  • NCT01402336Phase 3Completed43 enrolled2011

    GnRH Antagonist Versus GnRH Agonist in Polycystic Ovary Syndrome During in Vitro Fertilization - Embryo Transfer

    Seoul National University Hospital

    Infertility · Polycystic Ovary Syndrome

  • NCT04418908Completed40 enrolled2010

    Estrogen, Diabetes, and Endothelial Function

    University of Colorado, Denver

    Type 1 Diabetes

  • NCT01225835Phase 4Completed124 enrolled2010

    Progesterone Serum Levels in Subfertile Female Patients Undergoing in Vitro Fertilisation (IVF)

    Ferring Pharmaceuticals

    Infertility

  • NCT01204840Phase 2Completed38 enrolled2010

    Growth Hormone for Poor Responders in in Vitro Fertilization (IVF)

    Ottawa Fertility Centre

    Infertility · Poor Ovarian Reserve

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT01457703Completed62 enrolled2010

    Reproductive Hormonal Alterations in Obesity

    University of Colorado, Denver

    Obesity

  • NCT00883766Terminated172 enrolled2009

    Polycystic Ovary Syndrome (PCOS) and In Vitro Fertilization (IVF): A Comparison Between Standard Long Protocol Versus an Antagonist Protocol Starting on Day 1

    Fundacion Dexeus

    Polycystic Ovary Syndrome · In Vitro Fertilization

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT02437032Phase 4Completed100 enrolled2009

    Gonadotropin Type in Ovarian Stimulation

    IVI Madrid

    Infertility

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT00867659Completed20 enrolled2009

    The Role of Cetrotide Acetate in Prevention of Ovarian Hyperstimulation Syndrome (OHSS) in Oocyte Donors

    Virginia Center for Reproductive Medicine

    Ovarian Hyperstimulation Syndrome

  • NCT00866034Phase 4Terminated617 enrolled2009

    Cetrotide Treatment Optimization

    Bart CJM Fauser

    In Vitro Fertilization · Intracytoplasmic Sperm Injection

  • ISRCTN84867406124 enrolled2009

    The use of a flexible (GnRH) antagonist versus minidose long GnRH agonist for ovarian stimulation in poor-responder patients undergoing the (IVF) program

    Al-Amal Maternity Hospital (Jordan)

    Poor ovarian response to ovarian stimulation in IVF

  • NCT00746031Phase 4Completed30 enrolled2008

    Novel MRI Strategies as a Non-invasive Biomarker in Women With Uterine Fibroids

    University of Edinburgh

    Fibroid · Leiomyoma

  • NCT01185704Phase 3Completed136 enrolled2008

    Analysis of Two Therapeutic With Cetrotide® in Polycystic Ovarian (PCO) Women in Assisted Reproductive Technology (ART)

    Merck KGaA, Darmstadt, Germany

    Polycystic Ovarian Syndrome

  • NCT01109654Completed2,175 enrolled2008

    An Observational Study of Cetrotide® Gonadotropin-releasing Hormone Antagonist (GnRH Antagonist) With GONAL-f® in Assisted Reproductive Technologies (ART)

    Merck KGaA, Darmstadt, Germany

    Infertility

  • NCT01219153Phase 2Completed136 enrolled2008

    Extended High Dose Letrozole Regimen Versus Short Low Dose Letrozole Regimen as an Adjuvant to GnRH Antagonist Protocol in the Management of Poor Responders Undergoing IVF-ET

    Cairo University

    Infertility

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT00667758Phase 2Completed104 enrolled2008

    Gonadotropin-Releasing Hormone (GnRH)-Antagonist Therapy in Rheumatoid Arthritis

    Betanien Hospital

    Rheumatoid Arthritis

  • NCT00670306Phase 3Completed528 enrolled2008

    Cetrorelix Pamoate IM Regimens in Patients With Symptomatic Benign Prostatic Hyperplasia (BPH)

    AEterna Zentaris

    Benign Prostatic Hypertrophy

  • NCT00663858Phase 3Completed420 enrolled2008

    Cetrorelix Pamoate in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)

    AEterna Zentaris

    Benign Prostatic Hypertrophy

  • NCT01079949Phase 2Terminated93 enrolled2007

    A Phase II Study to Assess the Efficacy and Safety of Luveris® (Lutropin Alfa) in Mid Follicular Phase for Controlled Ovarian Stimulation (COS) in Advanced Reproductive Age

    Merck KGaA, Darmstadt, Germany

    Infertility · Ovulation Induction

  • NCT00571870Completed80 enrolled2007

    Gonadotropin-releasing Hormone Antagonist on Triggering Day: A Randomized Controlled Study

    Seoul National University Bundang Hospital

    Infertility

  • NCT00449150Phase 3Terminated667 enrolled2007

    Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)

    AEterna Zentaris

    Benign Prostatic Hypertrophy

  • NCT00439829Phase 4Completed80 enrolled2007

    Synchronization of Follicle Wave Emergence and Ovarian Stimulation

    University of Saskatchewan

    Infertility

  • NCT00460642Completed130 enrolled2007

    GnRH Antagonist to Prepare Recipients for Embryo Transfer

    Institute for Human Reproduction (IHR)

    Infertility

  • NCT00633347Phase 4Completed570 enrolled2007

    Use of Antagonist Versus Agonist GnRH in Oocyte Recipient Endometrium Preparation

    Instituto Valenciano de Infertilidad, IVI VALENCIA

    Infertility

  • NCT00628121Completed31 enrolled2006

    Clinical Pharmacological Study of GnRH Antagonist, Cetrorelix for Healthy Female Volunteer

    Nippon Kayaku Co., Ltd.

    Premenopause

  • ISRCTN10841210600 enrolled2006

    Does the addition of Recombinant Luteinising Hormone (recLH) (Luveris) to a regimen of Recombinant Follicle Stimulating Hormone (recFSH) (Gonal-F) and Gonadotropin Releasing Hormone (GnRH) antagonist (Cetrotide) improve ovarian response and implantation rates in patients age >35 years undergoing in vitro fertilisation (IVF)/embryo transfer (ET)?

    VU University Medical Centre (VUMC) (Netherlands)

    Subfertility

  • NCT01112358Phase 2Completed58 enrolled2005

    Lutropin Alfa in Women at Risk of Poor Response

    Merck KGaA, Darmstadt, Germany

    Ovarian Stimulation

  • NCT00244452Phase 2Completed2005

    A Multinational, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Investigate the Efficacy, Safety and Duration of Effect of a Single Administration of Various Doses of Cetrorelix SR in Subjects With Histologically Confirmed Endometriosis

    Solvay Pharmaceuticals

    Endometriosis

  • NCT01005784Phase 4Completed146 enrolled2005

    Fixed Versus Flexible Gonadotropin-releasing Hormone (GnRH) Antagonist Initiation

    Aristotle University Of Thessaloniki

    Subfertility

  • ISRCTN7524847460 enrolled2005

    The effectiveness of preventing premature luteinizing hormone surge by cetrorelix in the controlled ovarian stimulation by letrozole and gonadotropin

    Shin Kong Hospital Research Department (Taiwan)

    Couples with unexplained or mild male factor infetility

  • ISRCTN14156709100 enrolled2003

    Pre-ablation endometrial preparation: a comparison between GnRH agonist leuporelin and GnRH antagonist Cetrorelix. A Randomised Controlled Trial.

    Department of Health

    Surgery: Transcervical Endometrial Resection (TCRE)

  • NCT00298025Phase 4Completed185 enrolled2003

    A Study to Compare the Safety and Efficacy of Cetrotide® 3 Milligram (mg) Versus Antagon™ in Women Undergoing Ovarian Stimulation

    EMD Serono

    Infertile Women Undergoing Assisted Reproductive Technology (ART)

  • NCT01109888Phase 1/2Withdrawn

    Administration of Increased Dose of GnRH Antagonist for Coasting for Decreasing the Risk for Ovarian Hyperstimulation Syndrome( OHSS)

    Wolfson Medical Center

    Administration of Increased Dose of GnRH Antagonist for Coasting for Decreasing the Risk for Ovarian Hyperstimulation Syndrome( OHSS)

  • NCT00505817Phase 4Completed

    GnRH Agonist and Antagonists in an Oocyte Donation Program

    Instituto Valenciano de Infertilidad, IVI VALENCIA

    Effect of Two Protocols of Ovarian Stimulation on Oocyte Quality

Sources: ClinicalTrials.gov, the EU Clinical Trials Information System and ISRCTN, deduplicated so a study registered in more than one registry is counted once. A study is listed when Cetrorelix is named as an intervention. A registered trial is a plan, not a result — registration says nothing about whether the peptide worked.